Abstract: A garment for ambulatory, physiological monitoring of a patient includes a belt, having first and second end portion with closures at the end portions to wrap around a user's chest, a strap having a first end coupled to a portion of the belt with the strap having a second end, a pair of shoulder strap portions each shoulder strap portion having a first end coupled together at the second end of the strap and a second end, and a back portion that joins the second ends of the pair of shoulder strap portions, with at least one of the belt, strap portions and back portion having an accommodation for carrying a sensor. Other embodiments are described.

Abstract: A garment for ambulatory, physiological monitoring of a patient includes a belt, having first and second end portion with closures at the end portions to wrap around a user's chest, a strap having a first end coupled to a portion of the belt with the strap having a second end, a pair of shoulder strap portions each shoulder strap portion having a first end coupled together at the second end of the strap and a second end, and a back portion that joins the second ends of the pair of shoulder strap portions, with at least one of the belt, strap portions and back portion having an accommodation for carrying a sensor. Other embodiments are described.

Abstract: A transdermal patch container (10) that includes a container body (16), a first compartment (24), and a second compartment (28) is disclosed. One or more first transdermal patches (34) may be stored in the first compartment (24). One or more second transdermal patches (36) may be stored in the second compartment (28). The first transdermal patches (34) differ from the second transdermal patches (36) in at least one respect. A number of features may be incorporated to reduce the potential of being able to withdraw second transdermal patches (36) out of the second compartment (28). For instance, second transdermal patches (36) may be required to be directed through a slot (44) to enter a second compartment (28i). A flap (66) may be positioned below such a slot (58) within a second storage compartment (28ii). A plurality of vertically spaced or staggered flaps (96) may be positioned within a second storage compartment (28iv).

Abstract: A container (100) for storing transdermal patches is disclosed. The container (100) includes a child-resistant mechanism (112) to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism (112) may include first and second access components (116, 120) that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components (116, 120) in a particular manner allows the container (100) to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components (116, 120) may be simultaneously engaged (e.g., depressed) to open the container (100). In another arrangement, the first and second access components (116, 120) may be engaged in series in a particular sequence to open the container (100).

Abstract: Systems and methods for monitoring a container (180) for storing a pharmaceutical product (190) are presented. The container (180) may be monitored (210) such that container movement may be detected (212) and logic may be provided for determining if the movement was authorized. In the event of unauthorized movement, an alarm (140) may be activated (214) to alert a user or stakeholder of the unauthorized movement. The movement of the pharmaceutical product container (180) may be detected by way of a motion sensor (120) such as an accelerometer. The alarm (140) may comprise an auditory or visual alarm as well as a network communication indicative of the activation of an alarm. The alarm (140) may be prevented or canceled (218).

Abstract: Systems and methods for managing use of a pharmaceutical product (112) are provided. The systems and methods utilize an external cover (150) and a container (110), along with a first material (160) and a pharmaceutical product (112) that are each contained within an internal space (116) that exists when the external cover (150) is in a closed position relative to the container (110). Release of the first material (160) may bond the external cover (150) to the container (110), may result in the first material (160) coming into contact with the pharmaceutical product (112), or both.

Abstract: A garment for ambulatory, physiological monitoring of a patient includes a belt, having first and second end portion with closures at the end portions to wrap around a user's chest, a strap having a first end coupled to a portion of the belt with the strap having a second end, a pair of shoulder strap portions each shoulder strap portion having a first end coupled together at the second end of the strap and a second end, and a back portion that joins the second ends of the pair of shoulder strap portions, with at least one of the belt, strap portions and back portion having an accommodation for carrying a sensor. Other embodiments are described.